Deepika Chenna on Her Contribution to XX Annual AATM Congress 2025 and 5th Joint Meeting of AATM–AABB
Deepika Chenna, Additional Professor, Department of Immunohematology and Blood Transfusion at Kasturba Medical College, shared on LinkedIn:
”Privileged to have contributed at the XX Annual AATM Congress 2025 and 5th Joint Meeting of AATM–AABB in Mumbai, where I delivered a lecture on “Co-ordinated Team Response in
Massive Transfusion”, served as a judge for the oral paper presentations, and also did a poster presentation.
Being part of discussions that influence national transfusion policies, donor safety frameworks, and the integration of emerging technologies in routine practice was truly inspiring.
Deeply grateful to the organizing committee for this wonderful opportunity and for curating such a rich scientific and networking experience.
Always thankful to Dr Shamee Shastry Mam for her constant guidance and support, which continues to make my academic journey more meaningful and enriching.
Thank you to all my colleagues and students for your constant support and collaboration, which played a crucial role.
Looking forward to continuing to contribute to the field of Transfusion Medicine.”

Stay updated with Hemostasis Today.
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis